OTTAWA / ACCESSWIRE / June 11, 2020 / The Health Research Foundation (HRF) of Innovative Medicines Canada (IMC) today announced details of the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research. IMC’s member companies have contributed $500,000 from the IMC COVID-19 Fund over three years, to support future pandemic preparedness in Canada. The research chair is intended to draw applications from early-career researchers affiliated with a recognized academic institution.
“The COVID-19 pandemic has shown us the value of research to planning and preparedness in Canada’s healthcare system,” said Mel Cappe, Chair of the HRF Board of Directors. “I am proud the HRF can support this crucial research through the generous contribution of the Canadian innovative pharmaceutical industry.”
The HRF has long supported research excellence and facilitated world-class scientists to work on the discoveries and innovations that keep our communities healthy, our economy thriving and enhance Canada’s health system sustainability. The creation of a research chair dedicated to pandemic preparedness, as well as to the role of healthcare and the healthcare sector in sustaining and growing our economy, will contribute to helping Canada look ahead to the next public health crisis and will ensure our country is well-prepared to effectively respond and recover.
“Investing in a research chair is one of the many ways our member companies are contributing to the fight against COVID-19,” said IMC President Pamela Fralick. “In addition to researching potential vaccines and treatments for the virus, we hope we can contribute to public policy and help Canadians prepare to tackle the next public health crisis.”
The HRF will issue a call for applications on June 11, along with guidelines which further articulate the scope of the research chair. The application form will also be available on the HRF website. A Selection Committee comprised of life sciences experts will review all submitted applications and make its selection of the successful applicant in summer 2020.
Learn more about the Research Chair in pandemic planning and the HRF.
About the HRF
Innovative Medicines Canada’s Health Research Foundation (HRF) is a non-profit organization that invests in health research in Canadian academic centres, and promotes the benefits and values of research-driven health innovation and health system sustainability in Canada. Innovative Medicines Canada members generously contribute to the HRF ensuring such research will continue to benefit Canadians.
For further information:
Hugh Scott
Executive Director, Strategic Alliances
Telephone: (613) 301-4594
E-mail: hscott@imc-mnc.ca
hrf-frs.com
SOURCE: Innovative Medicines Canada’s Health Research Foundation (HRF)
View source version on accesswire.com:
https://www.accesswire.com/593502/Health-Research-Foundation-Launches-Research-Chair-in-Pandemic-Preparedness
The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…
CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…
Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…
- Combination of evorpacept plus rituximab and lenalidomide (R2) generated complete responses (CR) in 92%…
Media ReleaseCOPENHAGEN, Denmark; December 7, 2025 Trial demonstrated treatment with fixed duration EPKINLY plus rituximab…
― Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at…